TRANSACTIONS - CEC CAPITAL

Cancel

Date：2021-07
/index.php?a=shows&catid=34&id=584
M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector.
Cancel

Date：2021-07
/index.php?a=shows&catid=34&id=584
M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector.
Cancel

Date：2021-07
/index.php?a=shows&catid=34&id=810
Huihe Healthcare, a global leading structural heart disease platform company, successfully completed its B round financing of several hundred of million of RMB. This financing was led by IDG Capital, with participation from existing shareholders Growth Ca
Cancel

Date：2021-06
/index.php?a=shows&catid=34&id=811
Chinese tea brand "CHALI" successfully completed a new round of financing of several hundred million RMB. The funding was led by GGV Capital, with continued investment from B-round lead investor Country Garden Venture Capital, as well as participation fro
Cancel

Date：2021-06
/index.php?a=shows&catid=34&id=812
closing of a RMB 200 million Series B+ financing round. The funding was led by Qiming Venture Partners, with participation from BioVenture, C&D Emerging Industry Investment, and existing shareholder Sino-Ocean Capital. CEC Capital Group acted as the e
Cancel

Date：2021-06
/index.php?a=shows&catid=34&id=813
On June 1, 2021, Stemirna announced the closing of a $200 million round of financing, led by China Merchants Capital, HongShan, King Lin investment, and WuXi AppTec, with participation from OrbiMed Advisors, Advantech Capital, Zhejiang Guotong Investment,
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=814
HYGEIA (6078.HK) announced the acquisition of a 98% stake in Suzhou Yongding Hospital for a transaction size of RMB 1.7 billion. With this acquisition, Ascendent Capital, the controlling shareholder of Yongding Hospital, has completely divested its owners
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=815
Genome Grecision, a rare domestic provider specializing in comprehensive molecular diagnostics solutions for hematological diseases, announced the closing of roughly RMB 200 million in Series C financing. This round of financing was jointly led by Sunland
Cancel

Date：2021-04
/index.php?a=shows&catid=34&id=566
Bliss Biopharmaceutical (Hangzhou) Co., Ltd. (“BlissBio”) announces the completion of over 400M CNY Series-B financing round. The financing was led by GL Ventures, the venture capital unit of Hillhouse Capital, with participation from Cormorant Asset Management, VMS Group, and Heda Biopharmaceutical Venture Capital. The Series B financing round was also supported by existing investors, Sherpa Healthcare Partners and Oriental Fortune Capital. CEC Capital Group acted as the exclusive financial advisor in the transaction.